Providing technology expertise and leadership in all aspects of AIR's business. Helping drive our vision with strategic thinking with strong business acumen and focused customer advocacy. My familiarity with compute architectures ranges from small embedded platforms/edge devices to enterprise-grade cloud ecosystems and hands-on cybersecurity analysis and autonomous system (robotics), design and implementations. This allows me to implement scalable designs and work on deployments that accommodate organizations of varied sizes and needs. I build value through organizational leadership and technology - and this been the core tenet of my decades of service and support. I also bring many lessons learned from numerous startups that I've been fortunate to contribute to - as well as several of my own startups and successful exits.

Silicon Valley startup, Level 42 AI, Inc’s software-defined hardware captures and synchronizes traditionally discarded or unobserved multi-modal data streams to predict and quantify health state, from short 5-to-30 second data snippets, similar in principle to the music identification Shazam app.UNMET NEED: In addition to the ‘classic‘ COVID-19 illness, COVID-19-associated multi-system inflammatory syndrome in children (MIS-C) has recently emerged as a complicated and potentially fatal outcome resulting in school and workplace closures. The world needs a fast, accurate, non-invasive, affordable mass screening test for COVID-19; such a test should safely manage entry to workplaces, airplanes, schools, stadiums, theaters, mass transit center, ports-of-entry, malls and restaurants.Level 42 AI, Inc is conducting clinical studies to discover and validate COVID-19 biosignatures with Johns Hopkins School of Medicine (JHM) and University of California-San Francisco (UCSF).The mass screening technology has the potential to detect and screen individuals and patients with COVID-19 remotely, from a distance, using non-invasive, non-intrusive, and non-contact technology. Accurate and rapid COVID-19 mass screening is complementary to vaccine development and deployment.Level 42 AI, Inc’s COVID-19 biosignature is an AI algorithm that deploys state-of-the-art, proprietary domain-adaptable machine learning techniques to elucidate and differentiate early cellular and tissue mechano-transduction changes and the body's immune response to SARS-CoV-2 infection.By combining and analyzing multiple synchronized data streams, Level 42 AI, Inc aims to unveil robust and distinct biosignatures for actionable insights on the symptoms and onset of COVID-19, MIS-C, asthma, COPD, cystic fibrosis, TB, pulmonary arterial hypertension, acute respiratory distress syndrome, carotid artery disease, coronary artery disease, congestive heart failure, pain, depression, more

Sympler deploys technology solutions in our three areas of competency: Location Tracking/Positioning (LIDAR/SLAM, GPS, UWB/RTLS), Robotics/Autonomy and Cybersecurity. We have extensive experience in product management and can manage a customer's complete product life cycle - from concept to market. We perform solution design and integration for clients ranging from the SMB to large enterprise . We have clients throughout the US, Hong Kong and Australia across numerous vertical markets such as data centers, logistics, mining, transportation, energy management and manufacturing.

I'm fortunate enough to spend most of my time building a company that's focused on autonomous solutions for the private security industry. On a daily basis I'm heavily involved in most aspects of our customer acquisition, support and fundraising activities. I drive our company vision and technology roadmap on cybersecurity, machine learning, physical robot design and manufacturing.